Lymphoma News and Research

RSS

Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.

The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of Helicobacter-induced MALT lymphoma

Research led by Dr. Anne Mueller at Stanford University School of Medicine demonstrates that successful eradication of Helicobacter may not prevent future aggressive gastric lymphoma since resting B cells are left behind.

25 Aug 2005

Protein thought to promote lymphoma by merely preventing cancer cells from dying appears to actively promote cancer cell growth

A protein previously thought to merely hinder the activity of a key cellular protein linked to cancer cell death, now appears to mimic the cellular signaling of that protein; potentially leading to the development of lymphoma.

22 Aug 2005

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

Researchers at The University of Texas M. D. Anderson Cancer Center and the National Cancer Institute have found that an experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma, even though prior therapy had eliminated virtually all of the B cells thought necessary to mount such a defense.

22 Aug 2005

People who drink alcohol have a lower risk of non-Hodgkin's lymphoma

People who drink alcohol have a lower risk of non-Hodgkin's lymphoma (NHL) than non-drinkers, researchers at Yale's Department of Epidemiology and Public Health (EPH) write in an article published in Lancet Oncology.

15 Aug 2005

MiRNA is opening up a whole new way of understanding carcinogenesis

Scientists mining vast, largely unexplored regions of the human genome have identified a small handful of mini-molecules that play a major role in the development of cancer and perhaps many other diseases.

15 Aug 2005

New laser therapy that destroys cancer cells but leaves healthy ones unharmed

Scientists at Stanford University have developed a new laser therapy that destroys cancer cells but leaves healthy ones unharmed. The new, non-invasive treatment is described in a study published in the Aug. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).

2 Aug 2005

Combined computed tomography (CT) and positron emission tomography (PET) - may detect the spread of head and neck cancer more accurately

"PET/CT is very helpful in determining where we should pinpoint our biopsies for recurrent disease," said Dr. Carol Shores, assistant professor of otolaryngology/head and neck surgery at UNC and the report's senior author. Shores is a member of the UNC Lineberger Comprehensive Cancer Center.

26 Jul 2005

Specialized immune-system B cells play dual role in triggering both kinds of immunity - innate and acquired

A specialized subpopulation of the antibody-producing B cells of the immune system plays a "double-barreled" role in triggering both kinds of immunity - innate and acquired, Duke University Medical Center immunologists have discovered.

26 Jul 2005

People who drink alcohol have a lower risk of non-Hodgkin's lymphoma

People who drink alcohol have a lower risk of non-Hodgkin’s lymphoma (NHL) than non-drinkers, researchers at Yale’s Department of Epidemiology and Public Health (EPH) wrote recently in an article published in Lancet Oncology.

19 Jul 2005

NIPA levels act as switch regulating cell division

Cells control mitosis (cell division) by assembling a biochemical switch to block it or by disassembling the switch to trigger it, according to investigators at St. Jude Children's Research Hospital and the Technical University of Munich.

18 Jul 2005

Novel treatment for ovarian cancer

The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States.

15 Jul 2005

New method may accelerate the way cancer-causing genes are found

Researchers at the University of Minnesota Cancer Center and the National Cancer Institute (NCI) have discovered a new method that could accelerate the way cancer-causing genes are found and could lead to a more accurate identification of the genes, according to two studies in the July 14, 2005, issue of Nature.

13 Jul 2005

Patients suffering from oral cancer have increased levels of certain bacteria in their saliva

Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals.

6 Jul 2005

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

Oregon Health & Science University researchers have measured genetic changes reflecting a drop in the body's ability to suppress inflammatory cells that attack nerve fibers and promote progression of multiple sclerosis.

27 Jun 2005

New discoveries in treatment for patients with non-Hodgkin's lymphoma

Three scientific studies - each highlighting new discoveries in treatment for patients with non-Hodgkin's lymphoma - were announced at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

Stem cells grown in lab mirror normal developmental steps

Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.

20 Jun 2005

Immunomedics awarded U.S. and Australian patents

Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

16 Jun 2005

If a dividing cell's activity is a pop song, then the same process in an immune cell is an extended-play dance remix

The basics of cell division are the same in both, but there's a heck of a lot more going on in immune cells, Johns Hopkins scientists have discovered.

10 Jun 2005

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.

9 Jun 2005

MabThera highly effective in treating rheumatoid arthritis

Results from the DANCER study presented today revealed that MabThera significantly improves symptoms in heavily treated patients who are affected by moderate-to-severe rheumatoid arthritis (RA), a painful and debilitating disease of the joints.

9 Jun 2005

Lymphoma News and Research

Further Reading

The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of Helicobacter-induced MALT lymphoma

Protein thought to promote lymphoma by merely preventing cancer cells from dying appears to actively promote cancer cell growth

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

People who drink alcohol have a lower risk of non-Hodgkin's lymphoma

MiRNA is opening up a whole new way of understanding carcinogenesis

New laser therapy that destroys cancer cells but leaves healthy ones unharmed

Combined computed tomography (CT) and positron emission tomography (PET) - may detect the spread of head and neck cancer more accurately

Specialized immune-system B cells play dual role in triggering both kinds of immunity - innate and acquired

People who drink alcohol have a lower risk of non-Hodgkin's lymphoma

NIPA levels act as switch regulating cell division

Novel treatment for ovarian cancer

New method may accelerate the way cancer-causing genes are found

Patients suffering from oral cancer have increased levels of certain bacteria in their saliva

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

New discoveries in treatment for patients with non-Hodgkin's lymphoma

Stem cells grown in lab mirror normal developmental steps

Immunomedics awarded U.S. and Australian patents

If a dividing cell's activity is a pop song, then the same process in an immune cell is an extended-play dance remix

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

MabThera highly effective in treating rheumatoid arthritis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News